Louisiana · A9555

Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in Louisiana

Louisiana Medicare Avg
$540.96
27% above national avg
National Medicare Avg
$425.12
All states combined
Billed Charge (LA)
$1,157.45
What providers submit
Est. Commercial (LA)
$1,527.41
National avg: $1,194.12
Est. Cash / Self-Pay (LA)
$827.44
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

8.5K
Services in LA
86
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Louisiana

Provider Medicare Services
Fileccia, Russell M.D. $656.79 812
Katikaneni, Pavan MD $640.65 387

Louisiana Pricing in Context

In Louisiana, CPT code A9555 (Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries) carries an average Medicare payment of $540.96 — 27% above the national benchmark of $425.12. 86 providers across the state submitted claims for this procedure in 2023, performing 8.5K total services. Individual payments in LA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Louisiana is $1,157.45, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Louisiana sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Louisiana lands near $1,527.41, with self-pay cash prices typically around $827.44. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cost in Louisiana?

The average Medicare payment for Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in Louisiana is $540.96, which is 27% above the national average of $425.12. Providers in LA typically bill $1,157.45 for this procedure.

What does Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cost with insurance in Louisiana?

With commercial insurance in Louisiana, Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries costs an estimated $1,527.41. Without insurance, the estimated cash price is $827.44. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in Louisiana?

86 providers in Louisiana billed Medicare for Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in 2023, performing 8.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cheaper in Louisiana than the national average?

No — Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries costs 27% above the national average in Louisiana. The state average Medicare payment is $540.96 compared to $425.12 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial